Private#25 of 34 in this industry1 market
Optel Group
pharma serialisation and track-and-trace (unit-level serialsaggregationEPCIS exchangeverification for DSCSA / EU FMD)
Revenue—not disclosed
Markets named in1across this research
Incumbent in1the one to displace
Rank in industry25 / 34by revenue
01
Where it competes
Every market in this research that names Optel Group. Where it is the named incumbent it leads the list. The entry signal is the market’s, not the company’s — it says how open that market is to someone new.
| Market | Role | Share | Entry signal |
|---|---|---|---|
| Pharmaceutical Serialisation & Track-and-Trace (DSCSA, EU FMD, EPCIS, Aggregation) 3254 Pharmaceutical and medicine manufacturing |
Incumbent | — | 45% entry signal |
02
Others in Pharmaceutical and medicine manufacturing
Ranked by revenue. Companies that disclose none follow, ordered by how many markets name them.
| 1 | IQVIA NYSE:IQV | $6.6B |
| 2 | Genpact NYSE:G | $5.1B |
| 3 | Veeva NYSE:VEEV | $3.2B |
| 4 | Certara Private | $50M |
| 5 | ArisGlobal Private | — |
| 6 | Ennov Private | — |
| 7 | EXTEDO Private | — |
| 8 | Oracle Health Private | — |
| 9 | AcuityMD Private | — |
| 10 | Adents Private | — |
| 11 | Antares Vision Private | — |
| 12 | Axway Private | — |
| 13 | Cognizant NASDAQ:CTSH | — |
| 14 | Definitive Healthcare Private | — |
| 15 | DXC Technology NYSE:DXC | — |
| 16 | Freyr Solutions Private | — |
| 17 | Generis Private | — |
| 18 | Graph AI (Graph Safety) Private | — |
| 19 | Kivo Private | — |
| 20 | Komodo Health Private | — |
| 21 | Körber Private | — |
| 22 | LORENZ Life Sciences Group Private | — |
| 23 | LSPedia Private | — |
| 24 | Movilitas Private | — |
| 25 | Optel Group Private | — |
And 9 more — see every company.
Company details are from the search.cos database (snapshot 2026-10-18); market roles, shares and sourced revenue are from the research records linked above. Filed under the industry it serves — a software vendor sits with the industry that buys from it. Ranks convert currencies at approximate rates to put companies in order; every figure shown is in the currency it was reported in.